IP Library Granted Patent US 11,464,991
Granted Patent B2
US 11,464,991 · App. 16/717,566 · Granted Oct 11, 2022

Wearable cardiac defibrillator (WCD) system controlling conductive fluid deployment

Inventors: Daniel Ralph Piha (Bellevue, WA); Joseph Leo Sullivan (Kirkland, WA); Phillip Dewey Foshee, Jr. (Woodinville, WA); David Peter Finch (Bothell, WA); Isabelle Banville (Newcastle, WA); Laura Marie Gustavson (Redmond, WA); Kenneth Frederick Cowan (Kirkland, WA); Richard C. Nova (Seattle, WA); Robert Reuben Buchanan (Bothell, WA); Krystyna Szul (Seattle, WA); Gregory T. Kavounas (Bellevue, WA)
Assignee: West Affum Holdings Corp.
A61N1/3918A61N1/046A61N1/0496A61N1/3625A61N1/3904A61N1/3925A61N1/3987
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,464,991
App. No.
16/717,566
Granted
Oct 11, 2022
Kind
B2
Abstract

In some embodiments, a wearable medical device system includes a processor configured to determine whether a patient requires electrical therapy to be provided via a plurality of therapy electrodes, the electrical therapy comprising discharging at least a portion of a stored electrical charge from an energy storage module, and if so, cause a fluid deploying mechanism to deploy a portion of the stored fluid to an interface between at least two therapy electrodes and the patient's skin prior to providing the electrical therapy, the deployed portion of fluid adapted to decrease the impedance measured by an impedance measurement circuit, and cause the fluid deploying mechanism to deploy an additional portion of fluid in response to the impedance measured by the impedance measurement circuit increasing above a threshold during the electrical therapy.

Claims (38)

1. A wearable medical device system, comprising:

an energy storage module configured to store an electrical charge and discharge at least a portion of the stored electrical charge;

a plurality of therapy electrodes, coupled to the energy storage module, configured to be applied to a patient's skin at two or more respective patient locations of the patient;

an impedance measurement circuit configured to measure an impedance between at least two of the plurality of therapy electrodes;

a fluid deploying mechanism configured to store a fluid and to deploy at least a portion of the stored fluid; and

a processor coupled to the energy storage module, impedance measurement circuit and the fluid deploying mechanism, the processor configured to:

determine whether the patient requires electrical therapy to be provided to the patient via the plurality of therapy electrodes, the electrical therapy comprising discharging at least a portion of the stored electrical charge from the energy storage module,

responsive to a determination that the patient requires electrical therapy, cause the fluid deploying mechanism to deploy a portion of the stored fluid to an interface between at least two of the plurality therapy of electrodes and the patient's skin at the respective patient locations prior to providing the electrical therapy, the deployed portion of fluid adapted to decrease the impedance measured by the impedance measurement circuit, and

cause the fluid deploying mechanism to deploy an additional portion of fluid in response to the impedance measured by the impedance measurement circuit increasing above a threshold during the electrical therapy.

2. The wearable medical device system of claim 1 , further comprising a support structure wearable by the patient to support at least the plurality of therapy electrodes, the impedance measurement circuit, and the processor.

3. The wearable medical device system of claim 1 , wherein the processor is configured to operate the wearable medical device system as a wearable cardioverter defibrillator (WCD).

4. The wearable medical device system of claim 1 , wherein the fluid deploying mechanism comprises a first reservoir containing the fluid and a second reservoir containing an additional fluid, wherein the fluid is to be deployed during a first type of electrical therapy, and the additional fluid is to be deployed during a second type of electrical therapy.

5. The wearable medical device system of claim 4 , wherein the first type of electrical therapy comprises defibrillation, and the second type of electrical therapy comprises pacing.

6. The wearable medical device system of claim 1 , wherein the processor is configured to cause the electrical therapy to be provided to the patient when the measured impedance meets a discharge condition.

7. The wearable medical device system of claim 6 , wherein the discharge condition comprises the measured impedance being below a discharge threshold value.

8. The wearable medical device system of claim 1 , wherein the processor is configured to discharge at least a portion of the stored electrical charge from the energy storage module in response to a timeout threshold elapsing after a previous deployment of a portion of the fluid.

9. A method to control deployment of conductive fluid in a wearable medical device system, the method comprising:

storing an electrical charge in an energy storage module;

measuring with an impedance measurement circuit an impedance between at least two therapy electrodes applied to a patient's skin at two or more respective patient locations of the patient;

determining whether the patient requires electrical therapy to be provided to the patient via the at least two therapy electrodes, the electrical therapy comprising discharging at least a portion of the stored electrical charge from the energy storage module,

deploying a portion of fluid stored in fluid storage module to an interface between the at least two therapy electrodes and the patient's skin at the respective patient locations prior to providing the electrical therapy, the deployed portion of fluid adapted to decrease the impedance measured by the impedance measurement circuit responsive to a determination that the patient requires electrical therapy, and

deploying an additional portion of the stored fluid in response to the impedance measured by the impedance measurement circuit increasing above a threshold during the electrical therapy.

10. The method of claim 9 , wherein the fluid storage module comprises a first reservoir containing the fluid and a second reservoir containing an additional fluid, wherein the fluid is to be deployed during a first type of electrical therapy, and the additional fluid is to be deployed during a second type of electrical therapy.

11. The method of claim 10 , wherein the first type of electrical therapy comprises defibrillation, and the second type of electrical therapy comprises pacing.

12. The method of claim 9 , further comprising providing electrical therapy to the patient when the measured impedance meets a discharge condition.

13. The method of claim 12 , wherein the discharge condition comprises the measured impedance being below a discharge threshold value.

14. The method of claim 9 , wherein at least a portion of the stored electrical charge from the energy storage module is discharged in response to a timeout threshold elapsing after a previous deployment of a portion of the fluid.

15. One or more non-transitory machine readable media having instructions thereon that, when executed by a processor of a wearable medical device system, result in:

storing an electrical charge in an energy storage module;

measuring with an impedance measurement circuit an impedance between at least two therapy electrodes applied to a patient's skin at two or more respective patient locations of the patient;

determining whether the patient requires electrical therapy to be provided to the patient via the at least two therapy electrodes, the electrical therapy comprising discharging at least a portion of the stored electrical charge from the energy storage module,

deploying a portion of fluid stored in fluid storage module to an interface between the at least two therapy electrodes and the patient's skin at the respective patient locations prior to providing the electrical therapy, the deployed portion of fluid adapted to decrease the impedance measured by the impedance measurement circuit responsive to a determination that the patient requires electrical therapy, and

deploying an additional portion of the stored fluid in response to the impedance measured by the impedance measurement circuit increasing above a threshold during the electrical therapy.

16. The one or more non-transitory machine readable media of claim 15 , wherein the fluid storage module comprises a first reservoir containing the fluid and a second reservoir containing an additional fluid, and wherein the instructions, when executed, further result in the fluid being deployed during a first type of electrical therapy, and the additional fluid being deployed during a second type of electrical therapy.

17. The one or more non-transitory machine readable media of claim 16 , wherein the first type of electrical therapy comprises defibrillation, and the second type of electrical therapy comprises pacing.

18. The one or more non-transitory machine readable media of claim 15 , wherein the instructions, when executed, further result in providing electrical therapy to the patient when the measured impedance meets a discharge condition.

19. The one or more non-transitory machine readable media of claim 18 , wherein the discharge condition comprises the measured impedance being below a discharge threshold value.

20. The one or more non-transitory machine readable media of claim 15 , wherein the instructions, when executed, further result in at least a portion of the stored electrical charge from the energy storage module is discharged in response to a timeout threshold elapsing after a previous deployment of a portion of the fluid.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2025
From: PHYSIO-CONTROL, INC.; PHYSIO-CONTROL MANUFACTURING, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 070374/0038 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2025
From: PHYSIO-CONTROL DEVELOPMENT CO., LLC
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 070374/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2025
From: PIHA, DANIEL RALPH; SULLIVAN, JOSEPH LEO; FOSHEE, PHILLIP DEWEY, JR.; FINCH, DANIEL PETER; BANVILLE, ISABELLE; GUSTAVSON, LAURA MARIE; COWAN, KENNETH FREDERICK; NOVA, RICHARD C.; BUCHANAN, ROBERT REUBEN; SZUL, KRYSTYNA; KAVOUNAS, GREGORY T.
To: PHYSIO-CONTROL, INC.
Reel/Frame 070373/0204 →
SECURITY AGREEMENT Recorded Oct 4, 2023
From: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 065116/0049 →
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2023
From: KENNEDY LEWIS MANAGEMENT LP.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 065107/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2023
From: WEST AFFUM HOLDINGS CORP.
To: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
Reel/Frame 064290/0541 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Sep 28, 2020
From: WEST AFFUM HOLDINGS CORP.
To: KENNEDY LEWIS MANAGEMENT LP, AS AGENT
Reel/Frame 053910/0783 →